No Data
No Data
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $125 to $150
Merck & Company (MRK) Gets a Hold From Morgan Stanley
Buy Rating on Merck & Co. Amid Temporary Setbacks and Strong Growth Outlook
Express News | Merck & Co Inc : BofA Global Research Cuts Price Objective to $145 From $150
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating
Pertussis Treatment Market Projected to Hit US$ 5.3 Billion by 2034, With a 3.4% CAGR | Fact.MR Report
No Data
The Bunny Trader : This is due to the EPS guidance forecast being cut, so all the panic retail sellers sell because they dont know what is good![skull 💀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f480.png)
76545789 The Bunny Trader : no that's just how stocks work...it dips for many reasons after earnings. mostly to screw with impatient investors and so powers that be can load more cheaper...look at $DexCom (DXCM.US)$ it's like clockwork on a lot of them. there's a rhythm to it